학술논문
PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia June 2024 24(6):e267-e275
Subject
Language
ISSN
2152-2650